The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
Zossen, Germany
2009
Since the foundation of botiss biomaterials in 2009, botiss has become a leading developer, manufacturer and marketer of biomaterials for oral tissue regeneration. The botiss Regeneration System products have proven safety, efficacy and reliability in a variety of preclinical and clinical studies and daily clinical work with hundreds of thousands of patients worldwide. As a future-oriented company, botiss biomaterials invests substantially in cutting-edge research such as stem cells and growth factors. We develop new, innovative and patient-tailored materials and aim to optimize established indication-oriented products. The products of the botiss regeneration system have proven their success in terms of safety, efficacy, and reliability in a multitude of preclinical and clinical studies and, most importantly, in the daily clinical work with hundreds of thousands of patients treated worldwide. According to MDD 93/42/EEC botiss is a legal manufacturer of medical devices. With innovative products, we are continuously developing our holistic 360° system together with international experts. The products of the botiss regeneration system have proven their success in terms of safety, efficacy, and reliability in a multitude of preclinical and clinical studies and, most importantly, in the daily clinical work, with hundreds of thousands of patients treated worldwide.
+
Featured
About us - botiss biomaterials GmbH
... Since the foundation of botiss biomaterials ...
India
11-50 Employees
2016
We believe inventive product design and development is all about people. Those with ideas, those with the expertise, and most importantly, people whose lives are enhanced by innovative products. As a professional design and prototyping consultancy, our mission is to be the ideal partner on your product development journey. Our minds are open to each and every product idea, whether it’s the evolution of an existing product, or the development of a totally revolutionary concept. And thanks to more than 15 years’ successful experience, we couldn’t be better placed to make your idea tangible and commercial.
+
Featured
Biomaterials
... Biomaterials ...
Montreal, Canada
11-50 Employees
2010
Oligo Medic was founded in 2010 by biomaterials experts with a mission to bring paradigm-changing healthcare products to market. Oligo Medic is founded and rests upon continued innovation and discovery and the resolve to see ideas through. Find out more about our marketed product for cartilage repair!
+
Featured
Biomaterials for a better life
... Biomaterials for a better ...
United Kingdom
1-10 Employees
2020
We provide a personal, visible and bespoke service and collaborate closely with you to fully understand your specific requirements and deliver the right solution. We provide impartial advice, delivered with honesty and integrity, and pride ourselves on providing a fair, confidential and professional service to support your strategic ambitions. We provide in depth analysis to fully understand the project scope and build comprehensive plans, with multiple solutions, to meet your most demanding challenges. We know your products affect people's lives and we understand the criticality of identifying and achieving the specific level of quality for your individual application. DSR Biomaterials was formed out of a passion to deliver creative, intelligent and valuable solutions to customise the performance of materials. We pride ourselves on building long-term partnerships which provide valuable insight and deliver practical solutions, and our extensive network means we have access to a wealth of expertise and range of services, to ensure your ambitions are fully realised. Our extensive industry experience means we are ideally placed to provide creative and practical solutions which deliver tangible outcomes. Where possible, we adopt sustainable practices, promote sustainable materials and deliver sustainable solutions to achieve our goals and will continue to strive towards more sustainable outcomes through our own actions, as well as through our partnerships.
+
Featured
DSR Biomaterials - Surface Modification, Consultancy
... DSR Biomaterials - Surface Modification, ...
Georgetown, United States
11-50 Employees
2006
Today, as the adaptability of immune cells and the role that biomaterials play on immune-mediated tissue responses becomes better understood, there is a shift towards designing materials that can proactively modulate the immune system. Located in Austin Texas, DiFusion was founded in 2009 and has been dedicated to engineering and bringing to market a suite of patented immunomodulatory, tissue regenerating and antimicrobial polymers. DiFusion has assembled a team of leading clinical and research experts on their scientific advisory board:. Whang is actively involved in clinical and basic science research with a focus on the biology of spinal fusion and bone healing, bone grafting substitutes, and evidence-based medicine. Harborview is a referral center for 4 states and a quarter of the square mileage of the United States, where Dr. Cheng is a member of the American Society of Mechanical Engineers, the Lumbar Spine Research Society, the Orthopedic Research Society and the Spine Arthroplasty Society, among other professional societies. Stephen Badylak is a Professor in the Department of Surgery, and Deputy Director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh. ZFUZE is the first and only man-made material that consistently demonstrated the ability to shift the M1 to M2 phenotype in a rapid and predictable manner at Day 4-5.
+
Featured
When it comes to BioMaterials, Think Immune Response Doesn’t Matter?
... When it comes to BioMaterials, Think Immune Response Doesn’t Matter? ...
+
Featured
Nanova Biomaterials Inc.
... Nanova Biomaterials Inc. ...
Haag, Switzerland
10001+ Employees
Providing innovative solutions to help millions of people live healthier and more confident lives.
+
Featured
Ready-to-Use Biomaterial Systems
... ™ Ready-To-Use Biomaterial Systems have been primarily designed for bone graft materials such as DBM and Putty. ...
Seattle, United States
1-10 Employees
2007
Healionics aims to substantially improve health, longevity, and quality of life for kidney failure patients, while reducing treatment cost. Healionics’ STARgraft vascular graft has demonstrated superior resistance to both problems in human studies. STARgraft leverages Healionics’ platform STAR® (Sphere Templated Angiogenic Regeneration) biomaterial scaffold which is a breakthrough in biointegration and tissue regeneration. Healionics was recently honored to be selected as the “Most Valued Company” at the Investor Capital Expo.
+
Featured
Healionics - Innovative Solutions from Engineered Biomaterials
... Healionics - Innovative Solutions from Engineered Biomaterials ...
The Hague, Netherlands
11-50 Employees
We are a partner to your R&D team, enabling you to develop and optimize your products. CaP Biomaterials, LLC is a Wisconsin based, state-of-the-art manufacturing facility that specializes in high-quality, custom fabricated calcium phosphate products. Our materials are manufactured to customer specifications and are used in a wide array of biomedical applications including orthopedic, trauma, spine, dental, and soft tissue implants. This marked a transition from products to help modify postmortem biochemistry (food) to products to serve living biochemistry. Accomplishments included developing scaled up production methods for various specialized calcium phosphate materials. Osteotech was the first commercial provider of demineralized bone tissue which is a naturally osteoinductive material. In 2006, Larry founded CaP Biomaterials along with Bill Hubbard; a former colleague from Coors Biomedical. Since then Larry has overseen the expansion of CaP from producing a limited product line to producing a full line of standard and customized calcium phosphate biomaterials.
+
Featured
CaP Biomaterials
... CaP Biomaterials ...
San Juan, United States
11-50 Employees
2020
All latest data is reported as the number of molecules of carbon dioxide divided by the number of all molecules in air carbon, measured at Mauna Loa Observatory, Hawaii. By using seaweed, the fastest growing biomass on the planet, we are creating ways to achieve a new path to Gigaton-scale carbon capture. Our materials not only replace toxic, petroleum-based products, but also create next-generation alternatives – from fertilizers to cosmetics, clothing to packaging – that improve on industry standards while reducing emissions. By creating a Upcycled economy that turns Sargassum from harmful waste to materials and products for local use, we are solving a key environmental catastrophe affecting communities from West Africa to the Caribbean in a truly sustainable way.
+
Featured
We’re the world’s leading developer of ultra-regenerative, plant-based, advanced biomaterials from seaweed
... We’re the world’s leading developer of ultra-regenerative, plant-based, advanced biomaterials from ...
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about the results you have just received for Biomaterial
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 300 |
| Amount of suitable service providers | 219 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2006 |
| Youngest suiting company | 2020 |
A biomaterial is a substance that has been engineered to interact with biological systems for a medical purpose, either a therapeutic (treat, augment, repair, or replace a tissue function of the body) or a diagnostic one. These materials, which can be derived from nature or synthesized in the laboratory using a variety of chemical approaches utilizing metallic, polymeric, ceramic, or composite materials, are designed to perform, augment, or replace a natural function. Their application ranges from heart valves, hip joint replacements, dental implants, to more complex applications such as the delivery of drugs or genes into the body. Biomaterials are also central to tissue engineering and regenerative medicine strategies that aim to facilitate the repair or regeneration of damaged or diseased tissues and organs. The impact of biomaterials within their field is profound, significantly advancing the capabilities of medical treatments and interventions. They offer innovative solutions that enhance the quality of life for millions of people worldwide by improving the functionality and longevity of implants and prostheses, and by providing new methods for disease treatment that were not previously possible. Through ongoing research and development, the potential applications and effectiveness of biomaterials continue to expand, making them a crucial component of modern medicine and a focus of scientific exploration and innovation.
1. Eco-Friendly Composition
Biomaterials are derived from substances that occur naturally, making them more environmentally friendly than synthetic alternatives. This characteristic significantly reduces the ecological footprint associated with their production and disposal, offering a sustainable option for industries ranging from medical to construction.
2. Biocompatibility
One of the standout benefits of biomaterials, especially in the medical field, is their high level of biocompatibility. They can interact with human tissue without causing adverse reactions, making them ideal for implants, tissue engineering, and drug delivery systems. This compatibility reduces the risk of rejection and improves patient outcomes.
3. Renewability
Biomaterials often come from renewable resources, such as plants or animals, which can be replenished over time. This renewability contrasts sharply with the finite nature of many materials used in manufacturing, providing a more sustainable long-term solution.
4. Customizability
Thanks to advances in technology, biomaterials can be engineered to possess specific properties tailored to their intended use. Whether it's altering biodegradability for environmental applications or enhancing strength for construction purposes, the versatility of biomaterials opens up a wide range of possibilities.
While evaluating the different suppliers make sure to check the following criteria:
1. Material Quality and Consistency
Ensure the biomaterials meet industry standards for quality and show consistency across batches. This is crucial for applications in medical devices and biotechnology.
2. Regulatory Compliance
Verify that the supplier adheres to relevant regulatory requirements, including FDA or CE certifications for biomedical applications, to avoid legal and safety issues.
3. Supply Chain Reliability
Assess the supplier's ability to deliver materials on time and manage supply chain risks. A reliable supply chain is vital for maintaining production schedules.
4. Technical Support and Expertise
Choose suppliers that offer strong technical support and have expertise in biomaterials. This can be invaluable for troubleshooting and product development.
5. Cost-Effectiveness
While quality should not be compromised, evaluating the cost-effectiveness of the biomaterials is important for budget management and overall project feasibility.
6. Sustainability Practices
Consider suppliers that follow sustainable practices in the sourcing and production of biomaterials, aligning with environmental and social responsibility goals.
Biomaterials have revolutionized the healthcare industry, serving as the foundation for the development of advanced medical devices and implants. These materials are engineered to interact with biological systems for therapeutic or diagnostic purposes. For instance, biocompatible materials like titanium and certain polymers are widely used in orthopedic implants, dental implants, and surgical instruments. Their unique properties help in tissue regeneration and support the body's healing process, making them invaluable in surgeries and recovery. In the packaging sector, biomaterials offer an eco-friendly alternative to conventional plastics. Biodegradable polymers derived from renewable resources, such as polylactic acid (PLA), are used in creating sustainable packaging solutions. This application significantly reduces the environmental impact of packaging waste, aligning with the growing consumer demand for green products. Businesses benefit by enhancing their sustainability credentials and complying with increasingly stringent environmental regulations. The automotive industry leverages biomaterials to create lighter, more fuel-efficient vehicles. Components made from bio-based composites and polymers reduce the overall weight of the vehicle, improving fuel efficiency and reducing greenhouse gas emissions. This application of biomaterials is crucial for manufacturers aiming to meet global sustainability targets and consumer expectations for eco-friendly transportation options. These examples underscore the versatility and impact of biomaterials across different industries, driving innovations that are sustainable, efficient, and aligned with future technological advancements.
Biomaterials, essential in advancing healthcare and engineering, are currently at various Technology Readiness Levels (TRLs) depending on their application and composition. For instance, certain biomaterials utilized in medical implants and devices are at a high TRL, around 7 to 9, indicating they have been fully developed, tested, and are in clinical use. This high TRL is attributed to rigorous research and development efforts that have proven the biocompatibility, durability, and functionality of these materials in real-world medical scenarios. Conversely, emerging biomaterials designed for more innovative applications, such as organ regeneration or highly specific drug delivery systems, may reside at lower TRLs, around 3 to 6. This reflects their current stage of development, where they have shown promise in laboratory settings but are yet to undergo extensive clinical trials or receive regulatory approval. The disparity in TRLs across the biomaterials spectrum underscores the complexity of their development process, which involves not only creating materials that interact favorably with biological systems but also ensuring their safety, efficacy, and manufacturability at scale. As research continues and technology evolves, the TRL of these innovative biomaterials is expected to advance, paving the way for groundbreaking healthcare solutions.
In the Short-Term, advancements in biomaterials are set to significantly enhance medical devices and implants. The focus will be on developing materials that are more biocompatible and can integrate seamlessly with human tissue, reducing the risk of rejection and infection. We will also see the introduction of smart biomaterials capable of delivering drugs directly to a targeted area, improving the efficiency and effectiveness of treatments. For the Mid-Term, the evolution of biomaterials will likely pivot towards regenerative medicine. Researchers are expected to make strides in engineering biomaterials that can stimulate the body’s own repair mechanisms, potentially leading to breakthroughs in tissue engineering and organ regeneration. This phase will also witness the growth of biodegradable materials, which dissolve after fulfilling their purpose, minimizing long-term complications and the need for surgical removal. Looking into the Long-Term, the frontier of biomaterials could see the convergence with nanotechnology and artificial intelligence, paving the way for highly personalized medicine. Innovations may include programmable biomaterials that can adapt their properties in real-time, responding to the changing conditions of the body. This era could revolutionize not just how diseases are treated but also how they are detected, with biomaterials playing a central role in continuous health monitoring and disease prevention strategies.
